OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 109, Issue 5, Pages 879-882 (May 2002)


View previous. 38 of 61 View next.

Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy

Nikos N Markomichelakis, MDCorresponding Author Information11email address, Christina Canakis, MD21, Panayotis Zafirakis, MD11, Theodoros Marakis, MD11, Ioannis Mallias, MD31, George Theodossiadis, MD31

Received 8 November 2000; accepted 24 August 2001.

Abstract 

Objective

To report two cases of recurrent anterior uveitis with sectoral iris atrophy and ocular hypertension during attacks caused by cytomegalovirus (CMV).

Design

Two observational case reports.

Participants

Two immunocompetent patients with a history of recurrent unilateral hypertensive anterior uveitis with sectoral iris atrophy were referred to us with the presumptive diagnosis of herpetic uveitis.

Main outcome measures

Comprehensive ophthalmic examination, aqueous humor polymerase chain reaction (PCR), and peripheral blood serologic studies were performed on both patients.

Results

Examination of aqueous humor by PCR was positive for CMV and negative for herpesvirus. Serum IgG/IgM titers disclosed past CMV infection. Both patients responded well to antiviral therapy with ganciclovir. The final visual acuity level was 20/20 in both eyes of both patients.

Conclusions

CMV infection can produce recurrent attacks of anterior uveitis with clinical characteristics indistinguishable from those previously considered highly suggestive or even pathognomonic for herpetic infection. This observation has implications for the therapeutic management of such patients.

Manuscript no. 200786.

1 Ocular Inflammation and Immunology Service, Department of Ophthalmology, General Hospital of Athens, Athens, Greece

2 Vitreoretinal Service, Department of Ophthalmology, Tulane University, New Orleans, Louisiana, USA

3 Department of Ophthalmology, General Hospital of Athens, Athens Medical School, Athens, Greece

Corresponding Author InformationReprint requests to Nikos N. Markomichelakis, MD, Ocular Inflammation and Immunology Service, Department of Ophthalmology, General Hospital of Athens, Athens, Greece

1 The authors have no proprietary interest in any aspect of this study.

PII: S0161-6420(02)00961-2


View previous. 38 of 61 View next.